Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

A Tailored mHealth Intervention to Enhance Colposcopy Attendance in Patients at Risk for Cervical Cancer

Trial Status: active

This clinical trial tests how well a new mobile health (mHealth) text messaging program, Health Enhancement Resource System (HERS), works in disadvantaged patients at risk for cervical cancer. Cervical cancer is a slow-growing cancer that may not have symptoms but can be found with regular pap tests (a procedure in which cells are scraped from the cervix and looked at under a microscope). However, there is a large and unequal treatment gap among urban, underserved women. These women persistently have lower rates of attendance at follow-up appointments for abnormal test results, along with persistently greater rates of invasive cervical cancer incidence and mortality. Using HERS may help low-income women at risk for cervical cancer to attend follow-up appointments after an abnormal cervical test result, which may help them better understand how prevention and treatment can help them stay healthy by making it easier for them to keep their appointments.